3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine

CAS: 877399-52-5

Ref. AN-AG0036BC

Produktinformation

• Name: 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine
• Synonyme: [u'crizotinib', u'PF 02341066', u'PF 2341066', u'PF-02341066', u'PF-2341066', u'PF02341066', u'PF2341066', u'xalkori', u'Crizotinib', u'877399-52-5', u'Xalkori', u'(R)-crizotinib', u'PF-2341066', u'PF-02341066', u'PF 2341066', u'Crizotinib (PF-02341066)', u'crizotinibum', u'PF 02341066', u'3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine', u'UNII-53AH36668S', u'(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine', u'PF2341066', u'CHEMBL601719', u'Crizotinib (PF-2341066)', u'CHEBI:64310', u'53AH36668S', u'3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine', u'3-[(1r)-1-(2,6-Dichloro-3-Fluorophenyl)ethoxy]-5-(1-Piperidin-4-Yl-1h-Pyrazol-4-Yl)pyridin-2-Amine', u'PF 2341066;(R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine', u'Xalkori (TN)', u'C21H22Cl2FN5O', u'Crizotinib [USAN:INN]', u'VGH', u'PubChem19322', u'SCHEMBL93829', u'PF-2341066,Crizotinib', u'Crizotinib (JAN/USAN/INN)', u'PF-2341066(Crizotinib)', u'GTPL4903', u'QCR-32', u'Crizotinib, >=98% (HPLC)', u'PF-2341066 (Crizotinib)', u'PF-2341066 - Crizotinib', u'CTK5F8952', u'AOB2688', u'EX-A096', u'SYN1139', u'KTEIFNKAUNYNJU-GFCCVEGCSA-N', u'PF-02341066 (Crizotinib)', u'BCPP000116', u'AMX10152', u'ABP000131', u'ANW-47749', u'BDBM50306682', u'MFCD12407409', u'NSC749005', u'ZINC35902489', u'AKOS015901233', u'AKOS015995207', u'DB08865', u'GS-6178', u'KIN0000318', u'NSC-749005', u'PB11015', u'RL05464', u'KS-0000075X', u'NCGC00250400-01', u'NCGC00250400-09', u'NCGC00250400-12', u'2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-', u'BC622990', u'EN002685', u'HY-50878', u'SC-48062', u'AB0027203', u'TX-017903', u'BB 0261738', u'FT-0665224', u'SW202555-3', u'W9013', u'D09731', u'Q-3209', u'399P525', u'J-510370', u'BRD-K78431006-001-01-1', u'BRD-K78431006-001-03-7', u'I14-14837', u'3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[', u'877399-52-5, 877399-53-6 (acetate)', u'(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-am ine', u'(R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine', u'3-(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy-5-1-(4-piperidinyl)-1H-pyrazol-4-yl-2-Pyridinamine', u'3-[(R)-1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine', u'Crizotinib [USAN]', u'novel ALK inhibitors', u'D03ZBT', u'cc-190', u'2-Fluoro-3-iodophenylboronic acid', u'Crizotinib, 98% - 10MG 10mg', u'ACN-031532', u'CS-0029', u'CS-O-01256', u'CID11626560', u'A3020', u'PF02341066', u'S1068', u'A10712', u'C520390', u'C551994', u'D000077547', u'3-(2,6-dichloro-3-fluorobenzyloxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine', u'2-PYRIDINAMINE, 3-[(1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-[1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL]-', u'3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine'], (5-(Pyridin-3-Yl)-1,3,4-Oxadiazol-2-Yl)Methanamine, (R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-ylamine, 2-Pyridinamine, 3-[(1R)-1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy]-5-[1-(4-Piperidinyl)-1H-Pyrazol-4-Yl]-, 3-((R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine, Crizotinib, Pf 2341066, Pf-02341066, Pf2341066, Xalkori, [3-[[(R)-1-(2,6-Dichloro-3-fluorophenyl)ethyl]oxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]amine
• CAS: 877399-52-5
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 450.3367
• Formel: C₂₁H₂₂Cl₂FN₅O
• Reinheit: 99%
• Farbe/Form: Solid
• InChl: InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1
• InChI Key: KTEIFNKAUNYNJU-GFCCVEGCSA-N